According to Zacks, “Innophos, Inc., is one of the leading North American manufacturers of specialty phosphates, serving a diverse range of customers across multiple applications, geographies and channels. Innophos offers a broad suite of products used in a wide variety of food and beverage, consumer products, pharmaceutical and industrial applications. Innophos’ market-leading positions derive from its experience and dedication to customer service and innovation. “
Shares of Innophos Holdings (NASDAQ:IPHS) opened at 39.12 on Wednesday. The company’s 50-day moving average is $39.40 and its 200-day moving average is $39.11. The stock has a market capitalization of $752.71 million, a P/E ratio of 30.00 and a beta of 0.81. Innophos Holdings has a one year low of $22.06 and a one year high of $44.42.
Innophos Holdings (NASDAQ:IPHS) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.06. Innophos Holdings had a net margin of 3.47% and a return on equity of 9.83%. The company earned $181.90 million during the quarter, compared to the consensus estimate of $199.70 million. During the same quarter in the previous year, the firm earned $0.65 earnings per share. The firm’s quarterly revenue was down 16.3% on a year-over-year basis. On average, equities research analysts anticipate that Innophos Holdings will post $2.44 earnings per share for the current year.
In related news, Director Robert J. Zatta acquired 1,000 shares of Innophos Holdings stock in a transaction dated Friday, September 9th. The stock was acquired at an average price of $40.31 per share, for a total transaction of $40,310.00. Following the transaction, the director now owns 6,351 shares of the company’s stock, valued at $256,008.81. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 2.00% of the stock is currently owned by corporate insiders.
Several hedge funds have recently modified their holdings of IPHS. BB&T Securities LLC increased its stake in shares of Innophos Holdings by 0.3% in the first quarter. BB&T Securities LLC now owns 22,759 shares of the company’s stock valued at $703,000 after buying an additional 78 shares in the last quarter. Capstone Asset Management Co. boosted its position in shares of Innophos Holdings by 1.2% in the second quarter. Capstone Asset Management Co. now owns 8,360 shares of the company’s stock worth $353,000 after buying an additional 100 shares during the last quarter. Louisiana State Employees Retirement System boosted its position in shares of Innophos Holdings by 1.2% in the second quarter. Louisiana State Employees Retirement System now owns 8,600 shares of the company’s stock worth $363,000 after buying an additional 100 shares during the last quarter. Paradigm Asset Management Co. LLC boosted its position in shares of Innophos Holdings by 2.9% in the second quarter. Paradigm Asset Management Co. LLC now owns 3,600 shares of the company’s stock worth $152,000 after buying an additional 100 shares during the last quarter. Finally, US Bancorp DE boosted its position in shares of Innophos Holdings by 1.4% in the second quarter. US Bancorp DE now owns 13,756 shares of the company’s stock worth $581,000 after buying an additional 190 shares during the last quarter. Institutional investors and hedge funds own 93.29% of the company’s stock.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. Its segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and GTSP & Other.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.